Yi Luo, PhD

Dr.
Kaiser Permanente Southern California

Disclosure(s): Glaxosmithkline: Grant/Research Support; Moderna: Grant/Research Support; Pfizer: Grant/Research Support; Seqirus: Grant/Research Support

Poster(s):

• 1097 - Risk of Severe COVID-19 Disease in Individuals with Down syndrome: a Matched Cohort Study from a Large, Integrated Health Care System
  Friday, October 21, 2022

  12:15 PM – 1:30 PM US ET